Future research should address the outstanding question of how γδ T cells accumulate in B2M-deficient tumours, and whether the lack of CD8+ T cell activity might contribute to the establishment of an attractive niche for γδ T cells and other immune effector cells. This evidence concerns the gene B2M and neoplasm.